Kiora Pharmaceuticals, Inc. (KPRX) vs Senti Biosciences, Inc. (SNTI)
A side-by-side comparison of Kiora Pharmaceuticals, Inc. and Senti Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KPRX
Kiora Pharmaceuticals, Inc.
$2.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SNTI
Senti Biosciences, Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KPRX vs SNTI
growth of $100 · dividends reinvested · last 5yKPRX -99.8% (-72.4%/yr)SNTI -99.7% (-67.8%/yr)SNTI compounded faster over this window
KPRX SNTI
KPRX vs SNTI: by the numbers
- •KPRX is the larger company ($11M vs $10M market cap).
- •Both run net losses; KPRX's is the smaller (0.00% vs -90116.36% net margin).
Metrics side by side
Valuation
| Metric | KPRX | SNTI |
|---|---|---|
| P/S ratio | N/A | 182.90 |
| P/B ratio | 0.66 | N/A |
Profitability
| Metric | KPRX | SNTI |
|---|---|---|
| Gross margin | 0.00% | -16431.82% |
| Operating margin | 0.00% | -289668.18% |
| Net margin | 0.00% | -90116.36% |
| ROE | -65.18% | N/A |
| ROIC | -59.42% | -227.67% |
Growth (annualized)
| Metric | KPRX | SNTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -43.85% |
| Total return CAGR (5Y) | -67.06% | -67.75% |
Frequently asked
- How have KPRX and SNTI total returns compared?
- Over the past 5 years, KPRX delivered -67.06% and SNTI delivered -67.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.